Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years ...Middle East

The full 5-year results of a study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5400 patient-years of follow-up. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years )

Also on site :

• Opinion: Tolerance of diversity is central to San Diego’s economic growth
• ‘Deeply concerned’ over India press censorship, says X as accounts blocked
• Doctor accused of abusing patients treated California hospital like a ‘sexual playground,’ attorneys allege